Shaping the future of biomarker research in breast cancer to ensure clinical relevance

M. Carolina Hinestrosa, Kay Dickersin, Pamela Klein, Musa Mayer, Karin Noss, Dennis Slamon, George Sledge, Frances M. Visco

Research output: Contribution to journalReview articlepeer-review

Abstract

Each year, over 200,000 people are diagnosed with breast cancer in the United States. Although the use of biomarkers has the potential to guide preventive interventions and improve survival and quality of life, there have been few successes and many disappointments. In November 2005, the National Breast Cancer Coalition Fund convened a conference aimed at developing a patient-centred, strategic approach to breast cancer biomarker research. The consumers, clinicians, researchers, industry representatives and US regulators who served on the consensus panel developed a set of principles and recommendations to guide the field and ensure that biomarker research results in clinically important applications.

Original languageEnglish (US)
Pages (from-to)309-315
Number of pages7
JournalNature Reviews Cancer
Volume7
Issue number4
DOIs
StatePublished - Apr 2007

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Shaping the future of biomarker research in breast cancer to ensure clinical relevance'. Together they form a unique fingerprint.

Cite this